These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 28736835

  • 1. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.
    Heineke MH, van der Steen LPE, Korthouwer RM, Hage JJ, Langedijk JPM, Benschop JJ, Bakema JE, Slootstra JW, van Egmond M.
    Eur J Immunol; 2017 Oct; 47(10):1835-1845. PubMed ID: 28736835
    [Abstract] [Full Text] [Related]

  • 2. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
    Aleyd E, Heineke MH, van Egmond M.
    Immunol Rev; 2015 Nov; 268(1):123-38. PubMed ID: 26497517
    [Abstract] [Full Text] [Related]

  • 3. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4.
    van der Steen L, Tuk CW, Bakema JE, Kooij G, Reijerkerk A, Vidarsson G, Bouma G, Kraal G, de Vries HE, Beelen RH, van Egmond M.
    Gastroenterology; 2009 Dec; 137(6):2018-29.e1-3. PubMed ID: 19555692
    [Abstract] [Full Text] [Related]

  • 4. IgA Complexes in Plasma and Synovial Fluid of Patients with Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via FcαRI.
    Aleyd E, Al M, Tuk CW, van der Laken CJ, van Egmond M.
    J Immunol; 2016 Dec 15; 197(12):4552-4559. PubMed ID: 27913645
    [Abstract] [Full Text] [Related]

  • 5. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
    Breedveld A, van Egmond M.
    Front Immunol; 2019 Dec 15; 10():553. PubMed ID: 30984170
    [Abstract] [Full Text] [Related]

  • 6. FcαRI binding at the IgA1 CH2-CH3 interface induces long-range conformational changes that are transmitted to the hinge region.
    Posgai MT, Tonddast-Navaei S, Jayasinghe M, Ibrahim GM, Stan G, Herr AB.
    Proc Natl Acad Sci U S A; 2018 Sep 18; 115(38):E8882-E8891. PubMed ID: 30181292
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin A: magic bullet or Trojan horse?
    Heineke MH, van Egmond M.
    Eur J Clin Invest; 2017 Feb 18; 47(2):184-192. PubMed ID: 28024097
    [Abstract] [Full Text] [Related]

  • 8. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
    Herr AB, Ballister ER, Bjorkman PJ.
    Nature; 2003 Jun 05; 423(6940):614-20. PubMed ID: 12768205
    [Abstract] [Full Text] [Related]

  • 9. Blocking Fcα receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies.
    van der Steen LP, Bakema JE, Sesarman A, Florea F, Tuk CW, Kirtschig G, Hage JJ, Sitaru C, van Egmond M.
    J Immunol; 2012 Aug 15; 189(4):1594-601. PubMed ID: 22802416
    [Abstract] [Full Text] [Related]

  • 10. Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity.
    van Delft MAM, Aleyd E, van der Mast R, de Jong N, Boon L, Simons PJ, van Egmond M.
    Front Immunol; 2023 Aug 15; 14():1118539. PubMed ID: 37081893
    [Abstract] [Full Text] [Related]

  • 11. Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment.
    Wehrli M, Cortinas-Elizondo F, Hlushchuk R, Daudel F, Villiger PM, Miescher S, Zuercher AW, Djonov V, Simon HU, von Gunten S.
    J Immunol; 2014 Dec 01; 193(11):5649-59. PubMed ID: 25339672
    [Abstract] [Full Text] [Related]

  • 12. IgA Fc receptors.
    Monteiro RC, Van De Winkel JG.
    Annu Rev Immunol; 2003 Dec 01; 21():177-204. PubMed ID: 12524384
    [Abstract] [Full Text] [Related]

  • 13. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
    Valerius T, Stockmeyer B, van Spriel AB, Graziano RF, van den Herik-Oudijk IE, Repp R, Deo YM, Lund J, Kalden JR, Gramatzki M, van de Winkel JG.
    Blood; 1997 Dec 01; 90(11):4485-92. PubMed ID: 9373259
    [Abstract] [Full Text] [Related]

  • 14. Bivalent binding of IgA1 to FcalphaRI suggests a mechanism for cytokine activation of IgA phagocytosis.
    Herr AB, White CL, Milburn C, Wu C, Bjorkman PJ.
    J Mol Biol; 2003 Mar 28; 327(3):645-57. PubMed ID: 12634059
    [Abstract] [Full Text] [Related]

  • 15. FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA.
    Wu J, Ji C, Xie F, Langefeld CD, Qian K, Gibson AW, Edberg JC, Kimberly RP.
    J Immunol; 2007 Mar 15; 178(6):3973-82. PubMed ID: 17339498
    [Abstract] [Full Text] [Related]

  • 16. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S, Rossato E, Heming N, Monteiro RC.
    Autoimmun Rev; 2013 Apr 15; 12(6):666-9. PubMed ID: 23201915
    [Abstract] [Full Text] [Related]

  • 17. Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease.
    Bos A, Aleyd E, van der Steen LPE, Winter PJ, Heemskerk N, Pouw SM, Boon L, Musters RJP, Bakema JE, Sitaru C, Cogné M, van Egmond M.
    Front Immunol; 2022 Apr 15; 13():732977. PubMed ID: 35371001
    [Abstract] [Full Text] [Related]

  • 18. Immunoglobulin A-mediated protection against Bordetella pertussis infection.
    Hellwig SM, van Spriel AB, Schellekens JF, Mooi FR, van de Winkel JG.
    Infect Immun; 2001 Aug 15; 69(8):4846-50. PubMed ID: 11447159
    [Abstract] [Full Text] [Related]

  • 19. Immunoglobulin-binding sites of human FcalphaRI (CD89) and bovine Fcgamma2R are located in their membrane-distal extracellular domains.
    Morton HC, van Zandbergen G, van Kooten C, Howard CJ, van de Winkel JG, Brandtzaeg P.
    J Exp Med; 1999 Jun 07; 189(11):1715-22. PubMed ID: 10359575
    [Abstract] [Full Text] [Related]

  • 20. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcalphaRI (CD89).
    van der Pol W, Vidarsson G, Vilé HA, van de Winkel JG, Rodriguez ME.
    J Infect Dis; 2000 Oct 07; 182(4):1139-45. PubMed ID: 10979910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.